GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 198 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 198 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 198 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 198 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 198 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 198 | -98.2% | 0.00% | – |
| Q1 2022 | $46,000 | -53.1% | 11,067 | +44.6% | 0.00% | -100.0% |
| Q4 2021 | $98,000 | +9700.0% | 7,655 | +3689.6% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 202 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 202 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 202 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | – | 202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |